A comprehensive view of new use. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

HID Global acquires GuardRFID, a provider of real-time location services hardware, software solutions in healthcare space; acquisition includes active RFID tags, readers, exciters, software support for patient, staff safety

AstraZeneca and MSD’s Lynparza tablets combined with abiraterone and prednisone or prednisolone now approved in the EU for treatment of metastatic castration-resistant prostate cancer

GSK updates prescribing information for the ovarian cancer drug Zejula, limiting use to second-line maintenance therapy only to patients with certain mutation types; change was made at the request of FDA following review of Phase 3 clinical results

Army’s testbed ISR business jets are opening doors to new mission possibilities

Moderna completes submission to the FDA requesting emergency use authorization for Omicron-targeting bivalent COVID-19 booster vaccine; application is for a booster dose in adults age 18 years and older

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count